Phillips-Medisize Completes Acquisition Of Injectronics

Phillips-Medisize Corporation (the “Company”) today announced it has completed its previously announced acquisition of Injectronics Corporation (“Injectronics”). Terms of the transaction were not disclosed.

This acquisition expands Phillips-Medisize’s footprint, providing purpose-built facilities in the Northeastern United States, a global center of biopharmaceutical and medical device innovation, and opportunities for continued growth in these areas.

“This transaction, just like the recent acquisition of Medicom Innovation Partner, is consistent with Phillips-Medisize’s strategy of continued growth through the development of our people, the build-out of our processes and capabilities, and our investment in purpose-built facilities,” said Matt Jennings, Chairman, CEO and President of Phillips-Medisize Corporation. “Injectronics and Phillips-Medisize have similar cultures, with a passion for excellence and a focus on quality, service and innovation. Our shared qualities will ensure a seamless transition and I am very excited to welcome the Injectronics team on board.”

About Phillips-Medisize Corporation

Phillips-Medisize is a leading global outsource provider of design and manufacturing services to the drug delivery and combination products, consumable diagnostics and medical device, and specialty commercial markets. The company  as annual sales approaching $700 million with 80% of the total revenue coming from drug delivery, medical device,  rimary pharmaceutical packaging and diagnostic products such as: disposable insulin pens, glucose meters, specialty inhalation drug delivery devices, single use surgical devices and consumable diagnostic components.

Phillips-Medisize Corporation features a list of blue chip medical device, pharmaceutical and specialty commercial customers. The company partners with its customers to provide design and development services which accelerate speed to market of innovative products and then works with its customers to deploy advanced automated assembly and quality control technologies which reduce manufacturing cost while improving quality. The company’s core advantage is the knowledge of its people to integrate design, molding, and automation to drive low cost and high quality manufacturing solutions.

Phillips-Medisize Corporation is headquartered in Hudson, WI, and employs over 3,900 people in 17 production locations throughout the United States, Europe, Mexico and China. The company also operates a global design network with hubs in Hudson, WI and Struer, Denmark, supported by a global network in North America, Europe and China.